Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 249 entries
Sorted by: Best Match Show Resources per page
Sprouty2 protein in prediction of post-treatment ascites in epithelial ovarian cancer treated with adjuvant carbotaxol chemotherapy.

American journal of cancer research

Masoumi-Moghaddam S, Amini A, Wei AQ, Robertson G, Morris DL.
PMID: 26396926
Am J Cancer Res. 2015 Jul 15;5(8):2498-507. eCollection 2015.

Ascites development and resistance to chemotherapy with carbotaxol are common clinical problems in epithelial ovarian cancer, partly due to the activation of MAPK/ERK signaling. Sprouty proteins are negative modulators of MAPK/ERK pathway, but their role in predicting resistance to...

Cite
Masoumi-Moghaddam S, Amini A, Wei AQ, et al. Sprouty2 protein in prediction of post-treatment ascites in epithelial ovarian cancer treated with adjuvant carbotaxol chemotherapy. Am J Cancer Res. 2015;5(8):2498-507
Masoumi-Moghaddam, S., Amini, A., Wei, A. Q., Robertson, G., & Morris, D. L. (2015). Sprouty2 protein in prediction of post-treatment ascites in epithelial ovarian cancer treated with adjuvant carbotaxol chemotherapy. American journal of cancer research, 5(8), 2498-507.
Masoumi-Moghaddam, Samar, et al. "Sprouty2 protein in prediction of post-treatment ascites in epithelial ovarian cancer treated with adjuvant carbotaxol chemotherapy." American journal of cancer research vol. 5,8 (2015): 2498-507.
Masoumi-Moghaddam S, Amini A, Wei AQ, Robertson G, Morris DL. Sprouty2 protein in prediction of post-treatment ascites in epithelial ovarian cancer treated with adjuvant carbotaxol chemotherapy. Am J Cancer Res. 2015 Jul 15;5(8):2498-507. eCollection 2015. PMID: 26396926; PMCID: PMC4568786.
Copy Download .nbib Format: NLM
Role of Akt Isoforms Controlling Cancer Stem Cell Survival, Phenotype and Self-Renewal.

Biomedicines

Rivas S, Gómez-Oro C, Antón IM, Wandosell F.
PMID: 29518912
Biomedicines. 2018 Mar 07;6(1). doi: 10.3390/biomedicines6010029.

The cancer stem cell (CSC) hypothesis suggests that tumours are maintained by a subpopulation of cells with stem cell properties. Although the existence of CSCs was initially described in human leukaemia, less evidence exists for CSCs in solid tumours....

Cite
Rivas S, Gómez-Oro C, Antón IM, et al. Role of Akt Isoforms Controlling Cancer Stem Cell Survival, Phenotype and Self-Renewal. Biomedicines. 2018;6(1)doi: 10.3390/biomedicines6010029.
Rivas, S., Gómez-Oro, C., Antón, I. M., & Wandosell, F. (2018). Role of Akt Isoforms Controlling Cancer Stem Cell Survival, Phenotype and Self-Renewal. Biomedicines, 6(1), . https://doi.org/10.3390/biomedicines6010029
Rivas, Sergio, et al. "Role of Akt Isoforms Controlling Cancer Stem Cell Survival, Phenotype and Self-Renewal." Biomedicines vol. 6,1 (2018). doi: https://doi.org/10.3390/biomedicines6010029
Rivas S, Gómez-Oro C, Antón IM, Wandosell F. Role of Akt Isoforms Controlling Cancer Stem Cell Survival, Phenotype and Self-Renewal. Biomedicines. 2018 Mar 07;6(1). doi: 10.3390/biomedicines6010029. PMID: 29518912; PMCID: PMC5874686.
Copy Download .nbib Format: NLM
Uncovering the role of p53 splice variants in human malignancy: a clinical perspective.

OncoTargets and therapy

Surget S, Khoury MP, Bourdon JC.
PMID: 24379683
Onco Targets Ther. 2013 Dec 19;7:57-68. doi: 10.2147/OTT.S53876.

Thirty-five years of research on p53 gave rise to more than 68,000 articles and reviews, but did not allow the uncovering of all the mysteries that this major tumor suppressor holds. How p53 handles the different signals to decide...

Cite
Surget S, Khoury MP, Bourdon JC. Uncovering the role of p53 splice variants in human malignancy: a clinical perspective. Onco Targets Ther. 2013;7:57-68doi: 10.2147/OTT.S53876.
Surget, S., Khoury, M. P., & Bourdon, J. C. (2013). Uncovering the role of p53 splice variants in human malignancy: a clinical perspective. OncoTargets and therapy, 757-68. https://doi.org/10.2147/OTT.S53876
Surget, Sylvanie, et al. "Uncovering the role of p53 splice variants in human malignancy: a clinical perspective." OncoTargets and therapy vol. 7 (2013): 57-68. doi: https://doi.org/10.2147/OTT.S53876
Surget S, Khoury MP, Bourdon JC. Uncovering the role of p53 splice variants in human malignancy: a clinical perspective. Onco Targets Ther. 2013 Dec 19;7:57-68. doi: 10.2147/OTT.S53876. PMID: 24379683; PMCID: PMC3872270.
Copy Download .nbib Format: NLM
Enhanced Electrostatic Discrimination of Proteins on Nanoparticle-Coated Surfaces.

Journal of materials chemistry. B

Xu Y, Engel Y, Yan Y, Chen K, Moyano DF, Dubin PL, Rotello VM.
PMID: 24273645
J Mater Chem B. 2013 Oct 21;1(39). doi: 10.1039/C3TB20377H.

Two β-lactoglobulin (BLG) isoforms, BLGA and BLGB, were used a test bed for the differentiation of proteins using electrostatics. In these studies, the BLGA and BLGB binding to a highly charged, cationic gold nanoparticle (GNP) modified surface was investigated...

Cite
Xu Y, Engel Y, Yan Y, et al. Enhanced Electrostatic Discrimination of Proteins on Nanoparticle-Coated Surfaces. J Mater Chem B. 2013;1(39)doi: 10.1039/C3TB20377H.
Xu, Y., Engel, Y., Yan, Y., Chen, K., Moyano, D. F., Dubin, P. L., & Rotello, V. M. (2013). Enhanced Electrostatic Discrimination of Proteins on Nanoparticle-Coated Surfaces. Journal of materials chemistry. B, 1(39), . https://doi.org/10.1039/C3TB20377H
Xu, Yisheng, et al. "Enhanced Electrostatic Discrimination of Proteins on Nanoparticle-Coated Surfaces." Journal of materials chemistry. B vol. 1,39 (2013). doi: https://doi.org/10.1039/C3TB20377H
Xu Y, Engel Y, Yan Y, Chen K, Moyano DF, Dubin PL, Rotello VM. Enhanced Electrostatic Discrimination of Proteins on Nanoparticle-Coated Surfaces. J Mater Chem B. 2013 Oct 21;1(39). doi: 10.1039/C3TB20377H. PMID: 24273645; PMCID: PMC3835305.
Copy Download .nbib Format: NLM
CALMODULIN AND CALMODULIN-BINDING PROTEINS IN PLANTS.

Annual review of plant physiology and plant molecular biology

Zielinski RE.
PMID: 15012251
Annu Rev Plant Physiol Plant Mol Biol. 1998 Jun;49:697-725. doi: 10.1146/annurev.arplant.49.1.697.

Calmodulin is a small Ca2+-binding protein that acts to transduce second messenger signals into a wide array of cellular responses. Plant calmodulins share many structural and functional features with their homologs from animals and yeast, but the expression of...

Cite
Zielinski RE. CALMODULIN AND CALMODULIN-BINDING PROTEINS IN PLANTS. Annu Rev Plant Physiol Plant Mol Biol. 1998;49:697-725doi: 10.1146/annurev.arplant.49.1.697.
Zielinski, R. E. (1998). CALMODULIN AND CALMODULIN-BINDING PROTEINS IN PLANTS. Annual review of plant physiology and plant molecular biology, 49697-725. https://doi.org/10.1146/annurev.arplant.49.1.697
Zielinski, Raymond E.. "CALMODULIN AND CALMODULIN-BINDING PROTEINS IN PLANTS." Annual review of plant physiology and plant molecular biology vol. 49 (1998): 697-725. doi: https://doi.org/10.1146/annurev.arplant.49.1.697
Zielinski RE. CALMODULIN AND CALMODULIN-BINDING PROTEINS IN PLANTS. Annu Rev Plant Physiol Plant Mol Biol. 1998 Jun;49:697-725. doi: 10.1146/annurev.arplant.49.1.697. PMID: 15012251.
Copy Download .nbib Format: NLM
Proteomics analysis of plasma for potential biomarkers in the diagnosis of Alzheimer's disease.

Proteomics. Clinical applications

Liao PC, Yu L, Kuo CC, Lin C, Kuo YM.
PMID: 21136702
Proteomics Clin Appl. 2007 May;1(5):506-12. doi: 10.1002/prca.200600684. Epub 2007 Apr 19.

The objective of this study was to search for biological markers associated with Alzheimer's disease (AD). Plasma specimens obtained from ten pathologically diagnosed AD patients and ten non-demented (ND) control subjects were analyzed by a combination of 2-DE and...

Cite
Liao PC, Yu L, Kuo CC, et al. Proteomics analysis of plasma for potential biomarkers in the diagnosis of Alzheimer's disease. Proteomics Clin Appl. 2007;1(5):506-12doi: 10.1002/prca.200600684.
Liao, P. C., Yu, L., Kuo, C. C., Lin, C., & Kuo, Y. M. (2007). Proteomics analysis of plasma for potential biomarkers in the diagnosis of Alzheimer's disease. Proteomics. Clinical applications, 1(5), 506-12. https://doi.org/10.1002/prca.200600684
Liao, Pao-Chi, et al. "Proteomics analysis of plasma for potential biomarkers in the diagnosis of Alzheimer's disease." Proteomics. Clinical applications vol. 1,5 (2007): 506-12. doi: https://doi.org/10.1002/prca.200600684
Liao PC, Yu L, Kuo CC, Lin C, Kuo YM. Proteomics analysis of plasma for potential biomarkers in the diagnosis of Alzheimer's disease. Proteomics Clin Appl. 2007 May;1(5):506-12. doi: 10.1002/prca.200600684. Epub 2007 Apr 19. PMID: 21136702.
Copy Download .nbib Format: NLM
K-Cl cotransport function and its potential contribution to cardiovascular disease.

Pathophysiology : the official journal of the International Society for Pathophysiology

Adragna NC, Lauf PK.
PMID: 17949953
Pathophysiology. 2007 Dec;14(3):135-46. doi: 10.1016/j.pathophys.2007.09.007. Epub 2007 Oct 18.

K-Cl cotransport is the coupled electroneutral movement of K and Cl ions carried out by at least four protein isoforms, KCC1-4. These transporters belong to the SLC12A family of coupled cotransporters and, due to their multiple functions, play an...

Cite
Adragna NC, Lauf PK. K-Cl cotransport function and its potential contribution to cardiovascular disease. Pathophysiology. 2007;14(3):135-46doi: 10.1016/j.pathophys.2007.09.007.
Adragna, N. C., & Lauf, P. K. (2007). K-Cl cotransport function and its potential contribution to cardiovascular disease. Pathophysiology : the official journal of the International Society for Pathophysiology, 14(3), 135-46. https://doi.org/10.1016/j.pathophys.2007.09.007
Adragna, Norma C, and Lauf, Peter K. "K-Cl cotransport function and its potential contribution to cardiovascular disease." Pathophysiology : the official journal of the International Society for Pathophysiology vol. 14,3 (2007): 135-46. doi: https://doi.org/10.1016/j.pathophys.2007.09.007
Adragna NC, Lauf PK. K-Cl cotransport function and its potential contribution to cardiovascular disease. Pathophysiology. 2007 Dec;14(3):135-46. doi: 10.1016/j.pathophys.2007.09.007. Epub 2007 Oct 18. PMID: 17949953.
Copy Download .nbib Format: NLM
Multiple gene dysfunctions lead to high cancer-susceptibility: evidences from a whole-exome sequencing study.

American journal of cancer research

He ML, Chen Y, Chen Q, He Y, Zhao J, Wang J, Yang H, Kung HF.
PMID: 21984973
Am J Cancer Res. 2011;1(4):562-73. Epub 2011 Mar 30.

A total of $275 million has been launched to The Cancer Genome Atlas Project for genomic mapping of more than 20 types of cancers. The major challenge is to develop high throughput and cost-effective techniques for human genome sequencing....

Cite
He ML, Chen Y, Chen Q, et al. Multiple gene dysfunctions lead to high cancer-susceptibility: evidences from a whole-exome sequencing study. Am J Cancer Res. 2011;1(4):562-73
He, M. L., Chen, Y., Chen, Q., He, Y., Zhao, J., Wang, J., Yang, H., & Kung, H. F. (2011). Multiple gene dysfunctions lead to high cancer-susceptibility: evidences from a whole-exome sequencing study. American journal of cancer research, 1(4), 562-73.
He, Ming-Liang, et al. "Multiple gene dysfunctions lead to high cancer-susceptibility: evidences from a whole-exome sequencing study." American journal of cancer research vol. 1,4 (2011): 562-73.
He ML, Chen Y, Chen Q, He Y, Zhao J, Wang J, Yang H, Kung HF. Multiple gene dysfunctions lead to high cancer-susceptibility: evidences from a whole-exome sequencing study. Am J Cancer Res. 2011;1(4):562-73. Epub 2011 Mar 30. PMID: 21984973; PMCID: PMC3186053.
Copy Download .nbib Format: NLM
Genome-wide survey of ds exonization to enrich transcriptomes and proteomes in plants.

Evolutionary bioinformatics online

Liu LY, Charng YC.
PMID: 23091369
Evol Bioinform Online. 2012;8:575-87. doi: 10.4137/EBO.S10324. Epub 2012 Oct 08.

Insertion of transposable elements (TEs) into introns can lead to their activation as alternatively spliced cassette exons, an event called exonization which can enrich the complexity of transcriptomes and proteomes. Previously, we performed the first experimental assessment of TE...

Cite
Liu LY, Charng YC. Genome-wide survey of ds exonization to enrich transcriptomes and proteomes in plants. Evol Bioinform Online. 2012;8:575-87doi: 10.4137/EBO.S10324.
Liu, L. Y., & Charng, Y. C. (2012). Genome-wide survey of ds exonization to enrich transcriptomes and proteomes in plants. Evolutionary bioinformatics online, 8575-87. https://doi.org/10.4137/EBO.S10324
Liu, Li-Yu Daisy, and Charng, Yuh-Chyang. "Genome-wide survey of ds exonization to enrich transcriptomes and proteomes in plants." Evolutionary bioinformatics online vol. 8 (2012): 575-87. doi: https://doi.org/10.4137/EBO.S10324
Liu LY, Charng YC. Genome-wide survey of ds exonization to enrich transcriptomes and proteomes in plants. Evol Bioinform Online. 2012;8:575-87. doi: 10.4137/EBO.S10324. Epub 2012 Oct 08. PMID: 23091369; PMCID: PMC3475393.
Copy Download .nbib Format: NLM
Expression of 14-3-3 protein isoforms in mouse oocytes, eggs and ovarian follicular development.

BMC research notes

De S, Marcinkiewicz JL, Vijayaraghavan S, Kline D.
PMID: 22264317
BMC Res Notes. 2012 Jan 23;5:57. doi: 10.1186/1756-0500-5-57.

BACKGROUND: The 14-3-3 (YWHA) proteins are a highly conserved, ubiquitously expressed family of proteins. Seven mammalian isoforms of 14-3-3 are known (β, γ, ε, ζ, η, τ and, σ). These proteins associate with many intracellular proteins involved in a...

Cite
De S, Marcinkiewicz JL, Vijayaraghavan S, et al. Expression of 14-3-3 protein isoforms in mouse oocytes, eggs and ovarian follicular development. BMC Res Notes. 2012;5:57doi: 10.1186/1756-0500-5-57.
De, S., Marcinkiewicz, J. L., Vijayaraghavan, S., & Kline, D. (2012). Expression of 14-3-3 protein isoforms in mouse oocytes, eggs and ovarian follicular development. BMC research notes, 557. https://doi.org/10.1186/1756-0500-5-57
De, Santanu, et al. "Expression of 14-3-3 protein isoforms in mouse oocytes, eggs and ovarian follicular development." BMC research notes vol. 5 (2012): 57. doi: https://doi.org/10.1186/1756-0500-5-57
De S, Marcinkiewicz JL, Vijayaraghavan S, Kline D. Expression of 14-3-3 protein isoforms in mouse oocytes, eggs and ovarian follicular development. BMC Res Notes. 2012 Jan 23;5:57. doi: 10.1186/1756-0500-5-57. PMID: 22264317; PMCID: PMC3292963.
Copy Download .nbib Format: NLM
Binding Specificity of Native Odorant-Binding Protein Isoforms Is Driven by Phosphorylation and .

Frontiers in endocrinology

Nagnan-Le Meillour P, Joly A, Le Danvic C, Marie A, Zirah S, Cornard JP.
PMID: 30740091
Front Endocrinol (Lausanne). 2019 Jan 25;9:816. doi: 10.3389/fendo.2018.00816. eCollection 2018.

Odorant-binding proteins (OBP) are secreted in the nasal mucus at the vicinity of olfactory receptors (ORs). They act, at least, as an interface between hydrophobic and volatile odorant molecules and the hydrophilic medium bathing the ORs. They have also...

Cite
Nagnan-Le Meillour P, Joly A, Le Danvic C, et al. Binding Specificity of Native Odorant-Binding Protein Isoforms Is Driven by Phosphorylation and . Front Endocrinol (Lausanne). 2019;9:816doi: 10.3389/fendo.2018.00816.
Nagnan-Le Meillour, P., Joly, A., Le Danvic, C., Marie, A., Zirah, S., & Cornard, J. P. (2018). Binding Specificity of Native Odorant-Binding Protein Isoforms Is Driven by Phosphorylation and . Frontiers in endocrinology, 9816. https://doi.org/10.3389/fendo.2018.00816
Nagnan-Le Meillour, Patricia, et al. "Binding Specificity of Native Odorant-Binding Protein Isoforms Is Driven by Phosphorylation and ." Frontiers in endocrinology vol. 9 (2018): 816. doi: https://doi.org/10.3389/fendo.2018.00816
Nagnan-Le Meillour P, Joly A, Le Danvic C, Marie A, Zirah S, Cornard JP. Binding Specificity of Native Odorant-Binding Protein Isoforms Is Driven by Phosphorylation and . Front Endocrinol (Lausanne). 2019 Jan 25;9:816. doi: 10.3389/fendo.2018.00816. eCollection 2018. PMID: 30740091; PMCID: PMC6355697.
Copy Download .nbib Format: NLM
Proteomics Is Analytical Chemistry: Fitness-for-Purpose in the Application of Top-Down and Bottom-Up Analyses.

Proteomes

Coorssen JR, Yergey AL.
PMID: 28248279
Proteomes. 2015 Dec 03;3(4):440-453. doi: 10.3390/proteomes3040440.

Molecular mechanisms underlying health and disease function at least in part based on the flexibility and fine-tuning afforded by protein isoforms and post-translational modifications. The ability to effectively and consistently resolve these protein species or proteoforms, as well as...

Cite
Coorssen JR, Yergey AL. Proteomics Is Analytical Chemistry: Fitness-for-Purpose in the Application of Top-Down and Bottom-Up Analyses. Proteomes. 2015;3(4):440-453doi: 10.3390/proteomes3040440.
Coorssen, J. R., & Yergey, A. L. (2015). Proteomics Is Analytical Chemistry: Fitness-for-Purpose in the Application of Top-Down and Bottom-Up Analyses. Proteomes, 3(4), 440-453. https://doi.org/10.3390/proteomes3040440
Coorssen, Jens R, and Yergey, Alfred L. "Proteomics Is Analytical Chemistry: Fitness-for-Purpose in the Application of Top-Down and Bottom-Up Analyses." Proteomes vol. 3,4 (2015): 440-453. doi: https://doi.org/10.3390/proteomes3040440
Coorssen JR, Yergey AL. Proteomics Is Analytical Chemistry: Fitness-for-Purpose in the Application of Top-Down and Bottom-Up Analyses. Proteomes. 2015 Dec 03;3(4):440-453. doi: 10.3390/proteomes3040440. PMID: 28248279; PMCID: PMC5217385.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 249 entries